Fusariosis occurring in an ulcerated cutaneous CD8+ T cell lymphoma tumor

European Journal of Dermatology

Volumn 16, Issue 3, 2006, Pages 297-301

  Hsu, Chao Kai ^a   Hsu, Mark Ming Long ^a   Lee, Julia Yu Yun ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

CD8+ cutaneous T cell lymphoma; Fusarium; Hypopigmented mycosis fungoides; Voriconazole

Indexed keywords

AMPHOTERICIN B; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; EPIRUBICIN; GALLIUM; PREDNISOLONE; VINCRISTINE SULFATE; VORICONAZOLE;

ADULT; ANAMNESIS; ARTICLE; BLURRED VISION; CASE REPORT; CONFUSION; DEBRIDEMENT; DOSE RESPONSE; DRUG WITHDRAWAL; FEVER; FUNGUS ISOLATION; FUSARIUM; HEADACHE; HUMAN; LABORATORY TEST; LYMPHADENOPATHY; LYMPHOMA; MALE; NAUSEA; PROTEIN BLOOD LEVEL; PYODERMA GANGRENOSUM; SKIN BIOPSY; SKIN NECROSIS; SKIN NODULE; SKIN TUMOR; SKIN ULCER; T CELL LYMPHOMA; TUMOR SCINTISCANNING;

ANTIFUNGAL AGENTS; BASE SEQUENCE; CD8-POSITIVE T-LYMPHOCYTES; DNA PRIMERS; FUSARIUM; HUMANS; LYMPHOMA, T-CELL; MYCOSES; PYRIMIDINES; SKIN NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TRIAZOLES;

EID: 33646713417     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Dignani MC, Anaissie E. Human fusariosis. Clin Microbiol Infect 2004; 10(supp 1): 67-75.
2. Bodey GP, Boktour M, Mays S, Duvic M, Kontoyiannis D, Hachem R, Raad I. Skin lesions associated with Fusarium infection. J Am Acad Dermatol 2002; 47: 659-66.
3. Nelson PE, Dignani MC, Anaissie EJ. Taxonomy, biology, and clinical aspects of Fusarium species. Clin Microbiol Rev 1994; 7: 479-504.
4. Gupta AK, Baran R, Summerbell RC. Fusarium infections of the skin. Curr Opin Infect Dis 2000; 13: 121-8.
5. Nucci M, Anaissie E. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis 2002; 35: 909-20.
6. Iwen PC, Hinrichs SH, Rupp ME. Utilization of the internal transcribed spacer regions as molecular targets to detect and identify human fungal pathogens. Med Mycol 2002; 40: 87-109.
7. Martino P, Gastaldi R, Raccah R, Girmenia C. Clinical patterns of Fusarium infections in immunocompromised patients. J Infect 1994; 28(supp 1): 7-15.
8. Boutati El, Anaissie EJ. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management. Blood 1997; 90: 999-1008.
9. Musa MO, Al Eisa A, Halim M, Sahovic E, Gyger M, Chaudhri N, Al Mohareb F, Seth P, Aslam M, Aljurf M. The spectrum of Fusarium infection in immunocompromised patients with haematological malignancies and in non-immunocompromised patients: a single institution experience over 10 years. Br J Haematol 2000; 108: 44-8.
10. Perfect JR, Marr KA, Walsh TJ, Greenberg RN, DuPont B, de la Torre-Cisneros J, Just-Nubling G, Schlamm HT, Lutsar I, Espinel-Ingroff A, Johnson E. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis 2003; 36: 1122-31.
11. Boucher HW, Groll AH, Chiou CC, Walsh TJ. Newer systemic antifungal agents: pharmacokinetics, safety and efficacy. Drugs 2004; 64: 1997-2020.